BPG is committed to discovery and dissemination of knowledge
Articles in Press
7/31/2024 8:51:01 AM | Browse: 331 | Download: 12
| Category |
Pharmacology & Pharmacy |
| Manuscript Type |
Editorial |
| Article Title |
Timing impact on the initiation of pirfenidone therapy on idiopathic pulmonary fibrosis disease progression
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Basma M E Mohamed and Mohamed E A Abdelrahim |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mohamed E A Abdelrahim, PhD, Professor, Department of Clinical Pharmacy, Faculty of pharmacy, Beni-suef University, Beni suef 23343, Egypt. mohamed.abdelrahim@pharm.bsu.edu.eg |
| Key Words |
Idiopathic pulmonary fibrosis; Pirfenidone; Pirfenidone anti-inflammatory mechanism; Pirfenidone anti-fibrotic activity |
| Core Tip |
Pirfenidone is commonly used to treat idiopathic pulmonary fibrosis (IPF) in its early stages, but it has also demonstrated a notable impact on the disease in its advanced stages. In individuals with IPF who had substantial deterioration of their lung function, pirfenidone had a similar degree of efficacy. Pirfenidone appears to be safe when given to patients with advanced IPF, and it has a favorable benefit-risk profile, making it an appropriate treatment option for patients with idiopathic pulmonary fibrosis. |
| Citation |
Mohamed BME, Abdelrahim MEA. Timing impact on the initiation of pirfenidone therapy on idiopathic pulmonary fibrosis disease progression. World J Clin Cases 2024; 12(32): 6538-6542 |
 |
Received |
|
2024-06-11 14:29 |
|
Peer-Review Started |
|
2024-06-11 14:29 |
|
First Decision by Editorial Office Director |
|
2024-07-25 02:24 |
|
Return for Revision |
|
2024-07-25 02:24 |
|
Revised |
|
2024-07-25 20:28 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-07-31 02:40 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-07-31 08:51 |
|
Articles in Press |
|
2024-07-31 08:51 |
|
Edit the Manuscript by Language Editor |
|
2024-08-13 02:17 |
|
Typeset the Manuscript |
|
2024-08-22 14:11 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
